Proteomics International Laboratories Ltd (ASX:PIQ) advises that it is in the closing stages of finalising the detailed terms of its Exclusive Licence Agreement with Sonic Healthcare USA for use of the Company's PromarkerD predictive test for diabetic kidney disease in the United States.
Apiam Animal Health Limited (ASX:AHX) is pleased to release its full year results for the 6-months to 31 December 2022 (H1 FY23).
Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.
Apiam Animal Health Ltd (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire on the recent acquisitions the company has made in the mixed animal veterinary industry.
The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2022.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of two mixed animal veterinary businesses in strategic NSW regions (the Acquisitions), for total consideration of $11.2 million.
American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease
